123971-45-9

Basic information

• Product Name: 4-(5-CHLORO-2-THIENYL)-1,3-THIAZOL-2-AMINE
• Synonyms: ART-CHEM-BB B000341;IFLAB-BB F1386-0414;2-AMINO-4-(5-CHLOROTHIEN-2-YL)THIAZOLE;4-(5-CHLORO-2-THIENYL)-1,3-THIAZOL-2-AMINE;4-(5-CHLORO-THIOPHEN-2-YL)THIAZOL-2-YLAMINE;4-(5-CHLOROTHIEN-2-YL)-1,3-THIAZOL-2-AMINE;AKOS B000341;AKOS BBS-00006544
• CAS NO: 123971-45-9
• Molecular Formula: C₇H₅ClN₂S₂
• Molecular Weight: 216.71
• Mol File: 123971-45-9.mol
• Article Data: 1

Chemical Properties

• Melting Point: 129-130°C
• Boiling Point: 386°C at 760 mmHg
• Flash Point: 187.2°C
• Appearance: /
• Density: 1.535g/cm³
• Vapor Pressure: 3.65E-06mmHg at 25°C
• Refractive Index: 1.704
• Storage Temp.: 2-8°C
• PKA: 3.47±0.10(Predicted)
• CAS DataBase Reference: 4-(5-CHLORO-2-THIENYL)-1,3-THIAZOL-2-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-CHLORO-2-THIENYL)-1,3-THIAZOL-2-AMINE(123971-45-9)
• EPA Substance Registry System: 4-(5-CHLORO-2-THIENYL)-1,3-THIAZOL-2-AMINE(123971-45-9)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 123971-45-9(Hazardous Substances Data)

Usage

Uses

4-(5-Chloro-2-thienyl)-1,3-thiazol-2-amine is used as an allergy inhibitor.

InChI:InChI=1/C7H5ClN2S2/c8-6-2-1-5(12-6)4-3-11-7(9)10-4/h1-3H,(H2,9,10)

Downstream Products

• 376349-55-2 2,4-Dichloro-N-[4-(5-chloro-thien-2-yl)-1,3-thiazol-2-yl]-6-methylbenzenesulfonamide 
• 376349-43-8 2,4,6-Trichloro-N-[4-(5-chloro-thien-2-yl)-1,3-thiazol-2-yl]benzenesulfonamide 
• 376349-37-0 3-Chloro-N-[4-(5-chloro-thien-2-yl)-1,3-thiazol-2-yl]-2-methylbenzenesulfonamide 
• 376349-31-4 N-[4-(5-chloro-thien-2-yl)-1,3-thiazol-2-yl]-4-propylbenzenesulfonamide 
• 376349-49-4 N-[4-(5-chloro-thien-2-yl)-1,3-thiazol-2-yl][1,1'-biphenyl]-4-sulfonamide 

Relevant articles and documents

Based on isoxazole substitution of benzamide derivatives and anti-prostate cancer drug applications

The present invention discloses a class (I), formula (II) structure based on isoxazole substituted benzamide derivatives and antiprostate cancer drug applications, such isoxazole substituted benzamide derivatives, can effectively inhibit the activity of a